Dyslexia and ADHD share genetic links, DNA study shows

Scientists have shed new light on the genetic basis of dyslexia, showing how it overlaps with that of attention deficit hyperactivity disorder (ADHD).
Scientists have shed new light on the genetic basis of dyslexia, demonstrating its overlap with that of attention deficit hyperactivity disorder (ADHD).

A study led by the University of Edinburgh shows that dyslexia and ADHD often occur together and share many common genes. This sets them apart from other developmental and mental health diagnoses such as autism, bipolar disorder, and schizophrenia. The study is the first to explore the genetic links to dyslexia, which is believed to affect 10% of the population, in the context of neurodevelopmental and psychiatric traits.

The findings from the University of Edinburgh could help in customizing targeted educational, employment, and wellbeing support systems for people with dyslexia or ADHD, experts say. These findings contribute to our understanding of the biological factors underlying dyslexia, a condition that affects reading and spelling, and ADHD, a condition associated with difficulty concentrating hyperactivity, and impulsivity. Researchers at the University of Edinburgh analyzed large public anonymized datasets of genetic data on 10 neurodevelopmental and psychiatric conditions from the Psychiatric Genomics Consortium. Additionally, they used dyslexia genetic statistics from an analysis of around 1 million people in collaboration with 23andMe, a genomics and biotechnology company.

They used a statistical tool to find clusters of genetically similar traits for dyslexia and 10 neurodevelopmental and psychiatric traits including ADHD, anorexia nervosa and Tourette syndrome. They conducted more detailed analyses to identify specific genetic regions that overlap between dyslexia and ADHD.

In the study, researchers identified five genetic clusters, called latent genomic factors, among the 10 psychiatric traits. They found that ADHD was more closely linked to a factor related to attention and learning difficulties rather than factors associated with neurodevelopmental traits such as autism and Tourette syndrome.

PIPE-307: A New Remyelinating Agent for Multiple sclerosis

A drug called clemastine was found to have remyelinating effects in animals many years ago. Recently, a new drug called PIPE-307 has emerged, which may be an improvement over clemastine. It is more targeted towards the M1 receptor, believed to mediate remyelinating effects. PIPE-307 also has excellent penetration into the central nervous system and is highly potent. This video provides an overview of the research conducted on PIPE-307 so far and the ongoing trials.

Fruit and oats may increase the risk of diabetes, but berries may provide protection

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain, showed that consuming fruit, oats, and rye in childhood is associated with a higher risk of developing type 1 diabetes (T1D). On the other hand, eating berries is linked to a lower likelihood of developing the condition. T1D is an autoimmune disease in which the immune system attacks and destroys the insulin-producing islet cells in the pancreas, leading to insufficient insulin production to regulate blood sugar levels properly.

The exact trigger for the immune system’s attack is not known but is believed to involve a mix of genetic predisposition and environmental factors like viruses or certain foods. T1D is the most common form of diabetes in children and is on the rise worldwide. The global number of T1D cases is expected to double in just 20 years, from 8.4 million in 2021 to 17.4 million by 2040. Finland has the highest incidence of T1D globally, with 52.2 cases per 100,000 children under the age of 15, which is over five times higher than in the 1950s. Professor Suvi Virtanen, of the Finnish Institute for Health and Welfare in Helsinki, Finland, who led the research, stated, “Type 1 diabetes imposes a significant burden on the patient and their family, requiring lifelong treatment. It can lead to complications such as eye, heart, nerve, and kidney problems, shortened life expectancy, and substantial healthcare costs (around 1 million euros per patient in Finland). The rapid increase in type 1 diabetes in children suggests that environmental factors play a crucial role in the development of the disease. Identifying these factors will provide opportunities to develop strategies to prevent it and its complications.” 

While numerous food items have been linked to the attack on insulin-producing cells and T1D, there is a lack of high-quality evidence from prospective studies, and the existence of a link remains controversial. To address this, Professor Virtanen and colleagues explored whether diet in infancy and early childhood was associated with the development of T1D in thousands of children in Finland. They followed 5,674 children with genetic susceptibility to T1D from birth to the age of six. Food records completed by their parents repeatedly from the age of three months to 6 years provided information on the entire diet. By the age of six, 94 of the children had developed type 1 diabetes, and another 206 developed islet autoimmunity, putting them at a substantially increased risk of developing T1D in the next few years. When considering the entire diet, several foods were found to be associated with a higher risk of developing T1D.

“To the best of our knowledge, this is the first time a child’s entire diet has been considered at the same time,” says Professor Virtanen. The results show that the more fruit, oats or rye children ate, the more their risk of T1D increased. In contrast, eating strawberries, blueberries, lingonberries, raspberries, blackcurrants, and other berries appeared to protect against T1D. The more berries a child ate, the less likely they were to develop T1D. “Berries are particularly rich in polyphenols, plant compounds which may dampen the inflammation that is associated with the development of type 1 diabetes,” says Professor Virtanen.  “On the other hand, fruits may contain harmful substances that don’t occur in berries. For example, berries can be free of pesticides that are found on other fruits.”

Oats, bananas, fermented dairy products (such as yogurts) and wheat were associated with an increased risk of islet autoimmunity, whereas cruciferous vegetables, such as broccoli, cauliflower and cabbage, were associated with decreased risk. All of the associations were independent – they occurred regardless of the other foods eaten. “It is important to find out which factors in these foods are responsible for these associations,” says Professor Virtanen.  “Are the same causative factors or protective factors found in several foods? “If berries are found to contain a particular protective factor, for instance, either that substance or berries themselves could used to prevent T1D.” It is, however, too early to make any dietary recommendations.

Professor Virtanen says: “Many foods of the foods that we found to be associated with increased risk of type 1 diabetes and the disease process are considered part of a healthy diet and it is important that our results are replicated in other studies before anyone considers making changes to their child’s diet.”

Low ADHD risk from prenatal cannabis use study shows

8 in 10 cannabis users report combining marijuana with exercise, saying it boosts motivation and mood, eases pain

A new study reveals nuanced findings on the neuropsychiatric risks of prenatal cannabis exposure. The research found a slight increase in the risk of ADHD and a heightened vulnerability to cannabis use in offspring. These results highlight the need for continued caution and further investigation into the long-term effects of cannabis use during pregnancy.

A new study led by Prof. Ilan Matok and Hely Bassalov PharmD from the Department of Clinical Pharmacy at the School of Pharmacy in the Faculty of Medicine at Hebrew University in collaboration with Prof. Omer Bonne and Dr. Noa Yakirevich-Amir from the Department of Psychiatry at the Hadassah Medical Center, sheds light on the potential long-term neuropsychiatric risks associated with prenatal cannabis exposure. As the global trend toward cannabis legalization continues, the prevalence of cannabis use among pregnant women is on the rise, raising concerns about its impact on fetal development.

The study, a comprehensive systematic review and meta-analysis involving over 500,000 participants from observational studies, aimed to assess the potential risks posed by prenatal exposure to Δ9-tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis. THC is known to cross the placenta, potentially affecting the developing fetal brain.

The results of the study provide a nuanced understanding of the potential risks. Most notably, the findings indicate no significant association between prenatal cannabis exposure and an increased risk of autism spectrum disorder (ASD), psychotic symptoms, anxiety, or depression in offspring. However, the study did identify a slight increase in the risk of attention-deficit/hyperactivity disorder (ADHD) and a heightened vulnerability to cannabis consumption in children exposed to cannabis in utero.

“These findings suggest that while prenatal cannabis exposure does not appear to increase the risk for many neuropsychiatric disorders significantly, there is still a mild increase in the risk for ADHD and a greater likelihood of cannabis use in the offspring,” said Prof. Matok. “This calls for cautious interpretation, as it does not confirm the safety of cannabis consumption during pregnancy.”

The study emphasizes the importance of continued research in this area, especially given that most of the studies on the subject were conducted between the 1980s and early 2000s when cannabis was characterized by considerably lower Δ9-THC content than currently used compounds. Thus, findings presented in the current study may potentially underestimate the impact of contemporary prenatal cannabis exposure on long-term neuropsychiatric outcomes.

“While our study provides important insights, it is crucial to recognize that these results are not definitive. Pregnant women should be aware of the potential risks, and healthcare providers should continue to advise caution when it comes to cannabis use during pregnancy,” Prof. Matok added.

This research marks a significant step forward in understanding the complex relationship between prenatal cannabis exposure and neuropsychiatric outcomes in children. As the legal landscape surrounding cannabis continues to evolve, studies like this will be essential in guiding public health recommendations and ensuring the well-being of future generations.

Are you masking your Autism?


Our understanding of autism has evolved over the past forty years. In the past, autism was diagnosed using narrow criteria. Today, although it is still characterized by social and communication difficulties, rigid interests, and repetitive behaviours, the autism spectrum is much broader. There is also a growing awareness of the historical underdiagnosis of women and girls with autism. Instead of viewing autism as a single ‘disorder’ to be treated, it is increasingly discussed as a form of neurodivergence. The excerpt is from a lecture by Professor Francesca Happé CBE titled ‘Changes in the Concept of Autism’.